JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Eosinophilia in Pleural Effusions: a Speculative Negative Predictor for Malignancy
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Eosinophilia in Pleural Effusions: a Speculative Negative Predictor for Malignancy
Chu, Fang-Yeh; Liou, Ching-Biau; Sun, Jen-Tang; Bei, Chia-Hao; Liou, Tse-Hsuan; Tan, N-Chi; Yu, Yun-Chieh; Chang, Chih-Chun; Yen, Tzung-Hai; Su, Ming-Jang;
  PDF(new window)
 Abstract
Background: Eosinophilic pleural effusion (EPE) is an eosinophil count more than 10% on cytology of pleural samples. Recently, it was reported that malignancy had been the most prevalent cause inducing EPE. Therefore, we conducted an analysis on the prevalence and etiology of EPE and investigated the relationship between EPE and malignancy. Materials and Methods: Data for pleural cell differential count from patients receiving thoracentesis during the period from January 2008 to December 2013 were compared with clinical data and established diagnosis of patients obtained via electronic chart review. Results: A total of 6,801 requests of pleural cytology from 3,942 patients with pleural effusion who had received thoracentesis were available at Far Eastern Memorial Hospital from 2008 to 2013, and of these subjects, 115 (2.9%) were found to have EPE. The most frequent cause of EPE was malignancy (33.0%, n
 Keywords
Eosinophilic pleural effusion;lung cancer;malignancy;pleural fluid eosinophilia;
 Language
English
 Cited by
 References
1.
Adelman M, Albelda SM, Gottlieb J, et al (1984). Diagnostic utility of pleural fluid eosinophilia. Am J Med, 77, 915-20. crossref(new window)

2.
Chung CL, Chen YC, Chang SC (2003). Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest, 123, 1188-95. crossref(new window)

3.
Evison M, Holme J, Alaloul M, et al (2014). Olanzapine-induced eosinophilic pleuritis. Respir Med Case Rep, 14, 24-6.

4.
Heidecker J, Kaplan A, Sahn SA (2006). Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci, 332, 148-52. crossref(new window)

5.
Kalomenidis I, Light RW (2003). Eosinophilic pleural effusions. Curr Opin Pulm Med, 9, 254-60. crossref(new window)

6.
Kalomenidis I, Light RW (2004). Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med, 10, 289-93. crossref(new window)

7.
Kalomenidis I, Stathopoulos GT, Barnette R, et al (2005). Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions. Chest, 127, 2094-100. crossref(new window)

8.
Kim E, Kim C, Yang B, et al (2013). Intrapleural corticosteroid injection in eosinophilic pleural effusion associated with undifferentiated connective tissue disease. Tuberc Respir Dis (Seoul), 75, 161-4. crossref(new window)

9.
Krenke R, Nasilowski J, Korczynski P, et al (2009). Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J, 34, 1111-7. crossref(new window)

10.
Krenke R, Light RW (2011). Drug-induced eosinophilic pleural effusion. Eur Respir Rev, 20, 300-1. crossref(new window)

11.
Kwon BI, Hong S, Shin K, et al (2013). Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax. Am J Respir Crit Care Med, 188, 577-85. crossref(new window)

12.
Lin SS, Chen YC, Chang YL, et al (2014). Crystal amphetamine smoking-induced acute eosinophilic pneumonia and diffuse alveolar damage: a case report and literature review. Chin J Physiol, 57, 295-8. crossref(new window)

13.
Lin Q, Ouyang JS, Li JM, et al (2015). Eosinophilic pleural effusion due to Spirometra mansoni spargana: a case report and review of the literature. Int J Infect Dis, 34, 96-8. crossref(new window)

14.
Mohamed KH, Abdelhamid AI, Lee YC, et al (2002). Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Chest, 122, 576-80. crossref(new window)

15.
Nakamura Y, Ozaki T, Kamei T, et al (1993). Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol, 8, 605-11. crossref(new window)

16.
Oba Y, Abu-Salah T (2012). The prevalence and diagnostic significance of eosinophilic pleural effusions: a meta-analysis and systematic review. Respiration, 83, 198-208. crossref(new window)

17.
Oh Y, Kim JT, Kim MK, et al (2014). Eosinophilic pleuritis due to sparganum: a case report. Korean J Parasitol, 52, 541-3. crossref(new window)

18.
Ozkara SK, Turan G, Basyigit I (2007). Clinicopathologic significance of eosinophilic pleural effusions in a population with a high prevalence of tuberculosis and cancer. Acta Cytol, 51, 773-81. crossref(new window)

19.
Rubins JB, Rubins HB (1996). Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest, 110, 1271-4. crossref(new window)

20.
Strong DH, Westcott JY, Biller JA, et al (2003). Eosinophilic "empyema" associated with crack cocaine use. Thorax, 58, 823-4. crossref(new window)

21.
Wysenbeek AJ, Lahav M, Aelion JA, et al (1985). Eosinophilic pleural effusion: a review of 36 cases. Respiration, 48, 73-6.